(ESE) ESCO Technologies - Overview
Sector: TechnologyIndustry: Scientific & Technical Instruments | Exchange NYSE (USA) | Currency USD | Market Cap: 6.904m | Total Return 75.6% in 12m
Stock: Aerospace Components, Defense Filters, RF Test Systems, Utility Diagnostics
Total Rating 71
Risk 78
Buy Signal 0.94
| Risk 5d forecast | |
|---|---|
| Volatility | 34.7% |
| Relative Tail Risk | -3.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.84 |
| Alpha | 58.62 |
| Character TTM | |
|---|---|
| Beta | 0.954 |
| Beta Downside | 1.906 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.52% |
| CAGR/Max DD | 2.69 |
EPS (Earnings per Share)
Revenue
Description: ESE ESCO Technologies February 27, 2026
ESCO Technologies Inc. (NYSE:ESE) designs and manufactures engineered components for aerospace, defense, naval, and industrial markets. Its Aerospace & Defense segment supplies specialty filtration, electro-explosive devices, precision-tolerance machined parts, and signature-reduction solutions. The Utility Solutions Group focuses on diagnostic testing and decision-support tools for wind and solar power, while the RF Test & Measurement segment provides RF measurement systems, absorptive materials, and turnkey test facilities for research, compliance, medical, and security applications.
In the most recent fiscal year (FY 2024), ESCO reported revenue of $462 million, up 7.2% year-over-year, driven by a 12% increase in defense-related orders and a 9% rise in renewable-energy diagnostics sales. The company’s operating margin expanded to 9.4% from 8.1% in FY 2023, reflecting improved pricing power amid rising U.S. defense spending, which the Department of Defense has projected to grow at a 3.5% annual rate through 2028. Additionally, ESCO’s order backlog reached $215 million, indicating a solid pipeline across its three segments.
For deeper insight, you may want to explore ValueRay’s analytics platform.
Headlines to watch out for
- Defense spending increases boost aerospace component demand
- Utility grid modernization drives diagnostic solution sales
- RF test equipment demand rises with 5G deployment
- Supply chain disruptions impact manufacturing costs
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 304.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 3.03 > 1.0 |
| NWC/Revenue: 14.22% < 20% (prev 33.08%; Δ -18.86% < -1%) |
| CFO/TA 0.12 > 3% & CFO 276.6m > Net Income 304.4m |
| Net Debt (85.2m) to EBITDA (275.3m): 0.31 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.9m) vs 12m ago 0.19% < -2% |
| Gross Margin: 41.57% > 18% (prev 0.41%; Δ 4.12k% > 0.5%) |
| Asset Turnover: 57.42% > 50% (prev 55.48%; Δ 1.95% > 0%) |
| Interest Coverage Ratio: 10.30 > 6 (EBITDA TTM 275.3m / Interest Expense TTM 18.1m) |
Altman Z'' 4.72
| A: 0.07 (Total Current Assets 689.7m - Total Current Liabilities 518.4m) / Total Assets 2.40b |
| B: 0.58 (Retained Earnings 1.40b / Total Assets 2.40b) |
| C: 0.09 (EBIT TTM 186.7m / Avg Total Assets 2.10b) |
| D: 1.67 (Book Value of Equity 1.40b / Total Liabilities 838.1m) |
| Altman-Z'' Score: 4.72 = AA |
Beneish M -2.92
| DSRI: 0.83 (Receivables 334.0m/334.1m, Revenue 1.20b/995.8m) |
| GMI: 0.98 (GM 41.57% / 40.68%) |
| AQI: 1.18 (AQ_t 0.62 / AQ_t-1 0.52) |
| SGI: 1.21 (Revenue 1.20b / 995.8m) |
| TATA: 0.01 (NI 304.4m - CFO 276.6m) / TA 2.40b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of ESE shares?
As of March 26, 2026, the stock is trading at USD 288.77 with a total of 460,689 shares traded.
Over the past week, the price has changed by +8.03%, over one month by +3.46%, over three months by +44.08% and over the past year by +75.60%.
Over the past week, the price has changed by +8.03%, over one month by +3.46%, over three months by +44.08% and over the past year by +75.60%.
Is ESE a buy, sell or hold?
ESCO Technologies has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy ESE.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ESE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 285 | -1.3% |
| Analysts Target Price | 285 | -1.3% |
ESE Fundamental Data Overview March 21, 2026
P/E Trailing = 55.5437
P/E Forward = 25.3807
P/S = 5.8986
P/B = 4.4232
P/EG = 1.6685
Revenue TTM = 1.20b USD
EBIT TTM = 186.7m USD
EBITDA TTM = 275.3m USD
Long Term Debt = 125.0m USD (from longTermDebt, last quarter)
Short Term Debt = 20.5m USD (from shortTermDebt, last quarter)
Debt = 189.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 85.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.99b USD (6.90b + Debt 189.0m - CCE 103.8m)
Interest Coverage Ratio = 10.30 (Ebit TTM 186.7m / Interest Expense TTM 18.1m)
EV/FCF = 31.19x (Enterprise Value 6.99b / FCF TTM 224.1m)
FCF Yield = 3.21% (FCF TTM 224.1m / Enterprise Value 6.99b)
FCF Margin = 18.61% (FCF TTM 224.1m / Revenue TTM 1.20b)
Net Margin = 25.28% (Net Income TTM 304.4m / Revenue TTM 1.20b)
Gross Margin = 41.57% ((Revenue TTM 1.20b - Cost of Revenue TTM 703.6m) / Revenue TTM)
Gross Margin QoQ = 41.40% (prev 42.37%)
Tobins Q-Ratio = 2.91 (Enterprise Value 6.99b / Total Assets 2.40b)
Interest Expense / Debt = 1.52% (Interest Expense 2.88m / Debt 189.0m)
Taxrate = 19.13% (6.79m / 35.5m)
NOPAT = 151.0m (EBIT 186.7m * (1 - 19.13%))
Current Ratio = 1.33 (Total Current Assets 689.7m / Total Current Liabilities 518.4m)
Debt / Equity = 0.12 (Debt 189.0m / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = 0.31 (Net Debt 85.2m / EBITDA 275.3m)
Debt / FCF = 0.38 (Net Debt 85.2m / FCF TTM 224.1m)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.52% (Net Income 304.4m / Total Assets 2.40b)
RoE = 21.34% (Net Income TTM 304.4m / Total Stockholder Equity 1.43b)
RoCE = 12.04% (EBIT 186.7m / Capital Employed (Equity 1.43b + L.T.Debt 125.0m))
RoIC = 9.08% (NOPAT 151.0m / Invested Capital 1.66b)
WACC = 9.12% (E(6.90b)/V(7.09b) * Re(9.34%) + D(189.0m)/V(7.09b) * Rd(1.52%) * (1-Tc(0.19)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.07%
[DCF] Terminal Value 78.01% ; FCFF base≈179.7m ; Y1≈221.7m ; Y5≈378.3m
[DCF] Fair Price = 200.3 (EV 5.27b - Net Debt 85.2m = Equity 5.19b / Shares 25.9m; r=9.12% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 74.77 | EPS CAGR: 27.99% | SUE: 2.38 | # QB: 2
Revenue Correlation: 69.42 | Revenue CAGR: 9.67% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.13 | Chg7d=+0.000 | Chg30d=+0.030 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-09-30): EPS=8.06 | Chg7d=+0.000 | Chg30d=+0.355 | Revisions Net=+2 | Growth EPS=+33.8% | Growth Revenue=+19.7%
EPS next Year (2027-09-30): EPS=9.18 | Chg7d=+0.000 | Chg30d=+0.385 | Revisions Net=+2 | Growth EPS=+13.8% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.5% (Discount Rate 9.3% - Earnings Yield 1.8%)
[Growth] Growth Spread = +13.5% (Analyst 21.1% - Implied 7.5%)
P/E Forward = 25.3807
P/S = 5.8986
P/B = 4.4232
P/EG = 1.6685
Revenue TTM = 1.20b USD
EBIT TTM = 186.7m USD
EBITDA TTM = 275.3m USD
Long Term Debt = 125.0m USD (from longTermDebt, last quarter)
Short Term Debt = 20.5m USD (from shortTermDebt, last quarter)
Debt = 189.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 85.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.99b USD (6.90b + Debt 189.0m - CCE 103.8m)
Interest Coverage Ratio = 10.30 (Ebit TTM 186.7m / Interest Expense TTM 18.1m)
EV/FCF = 31.19x (Enterprise Value 6.99b / FCF TTM 224.1m)
FCF Yield = 3.21% (FCF TTM 224.1m / Enterprise Value 6.99b)
FCF Margin = 18.61% (FCF TTM 224.1m / Revenue TTM 1.20b)
Net Margin = 25.28% (Net Income TTM 304.4m / Revenue TTM 1.20b)
Gross Margin = 41.57% ((Revenue TTM 1.20b - Cost of Revenue TTM 703.6m) / Revenue TTM)
Gross Margin QoQ = 41.40% (prev 42.37%)
Tobins Q-Ratio = 2.91 (Enterprise Value 6.99b / Total Assets 2.40b)
Interest Expense / Debt = 1.52% (Interest Expense 2.88m / Debt 189.0m)
Taxrate = 19.13% (6.79m / 35.5m)
NOPAT = 151.0m (EBIT 186.7m * (1 - 19.13%))
Current Ratio = 1.33 (Total Current Assets 689.7m / Total Current Liabilities 518.4m)
Debt / Equity = 0.12 (Debt 189.0m / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = 0.31 (Net Debt 85.2m / EBITDA 275.3m)
Debt / FCF = 0.38 (Net Debt 85.2m / FCF TTM 224.1m)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.52% (Net Income 304.4m / Total Assets 2.40b)
RoE = 21.34% (Net Income TTM 304.4m / Total Stockholder Equity 1.43b)
RoCE = 12.04% (EBIT 186.7m / Capital Employed (Equity 1.43b + L.T.Debt 125.0m))
RoIC = 9.08% (NOPAT 151.0m / Invested Capital 1.66b)
WACC = 9.12% (E(6.90b)/V(7.09b) * Re(9.34%) + D(189.0m)/V(7.09b) * Rd(1.52%) * (1-Tc(0.19)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.07%
[DCF] Terminal Value 78.01% ; FCFF base≈179.7m ; Y1≈221.7m ; Y5≈378.3m
[DCF] Fair Price = 200.3 (EV 5.27b - Net Debt 85.2m = Equity 5.19b / Shares 25.9m; r=9.12% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 74.77 | EPS CAGR: 27.99% | SUE: 2.38 | # QB: 2
Revenue Correlation: 69.42 | Revenue CAGR: 9.67% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.13 | Chg7d=+0.000 | Chg30d=+0.030 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-09-30): EPS=8.06 | Chg7d=+0.000 | Chg30d=+0.355 | Revisions Net=+2 | Growth EPS=+33.8% | Growth Revenue=+19.7%
EPS next Year (2027-09-30): EPS=9.18 | Chg7d=+0.000 | Chg30d=+0.385 | Revisions Net=+2 | Growth EPS=+13.8% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.5% (Discount Rate 9.3% - Earnings Yield 1.8%)
[Growth] Growth Spread = +13.5% (Analyst 21.1% - Implied 7.5%)